Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones

Sep 24

DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.71% to $7.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.13% to 26,936.04 and Dow Jones Industrial Average falling 0.68% to 51,511.59.

The stock's fall snapped a three-day winning streak.

Corbus Pharmaceuticals Holdings Inc. closed 62.35% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 3.26% to $5.04, Fortress Biotech Inc. (FBIO) fell 4.49% to $2.34, and Viking Therapeutics Inc. (VKTX) rose 1.96% to $41.65.

Trading volume (787,242) eclipsed its 50-day average volume of 753,070.

Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/news/2669282439"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2669282439\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2669282439?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 05:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2669282439","market":"nz","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slid 1.71% to $7.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 26,936.04 and Dow Jones Industrial Average  falling 0.68% to 51,511.59. \n</p>\n<p>\n     The stock's fall snapped a three-day winning streak. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 62.35% below its 52-week high of $20.56, which the company achieved on October 20th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 3.26% to $5.04, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 4.49% to $2.34, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. (VKTX) rose 1.96% to $41.65. \n</p>\n<p>\n     Trading volume (787,242) eclipsed its 50-day average volume of 753,070. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-09-24 05:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slid 1.71% to $7.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 26,936.04 and Dow Jones Industrial Average  falling 0.68% to 51,511.59. \n</p>\n<p>\n     The stock's fall snapped a three-day winning streak. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 62.35% below its 52-week high of $20.56, which the company achieved on October 20th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 3.26% to $5.04, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 4.49% to $2.34, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. (VKTX) rose 1.96% to $41.65. \n</p>\n<p>\n     Trading volume (787,242) eclipsed its 50-day average volume of 753,070. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2669282439","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2669282439","pubTimestamp":1790198400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.71% to $7.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 26,936.04 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.The stock's fall snapped a three-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 62.35% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 3.26% to $5.04, Fortress Biotech Inc.  fell 4.49% to $2.34, and Viking Therapeutics Inc.  rose 1.96% to $41.65.Trading volume  eclipsed its 50-day average volume of 753,070.Data source: Dow Jones Market Data, FactSet. D","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"尽管当天亏损，Corbus Pharmaceuticals Holdings Inc. 股票仍跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1.5},"content_text":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.71% to $7.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 26,936.04 and Dow Jones Industrial Average  falling 0.68% to 51,511.59. \n\n\n     The stock's fall snapped a three-day winning streak. \n\n\n     Corbus Pharmaceuticals Holdings Inc. closed 62.35% below its 52-week high of $20.56, which the company achieved on October 20th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 3.26% to $5.04, Fortress Biotech Inc. (FBIO) fell 4.49% to $2.34, and Viking Therapeutics Inc. (VKTX) rose 1.96% to $41.65. \n\n\n     Trading volume (787,242) eclipsed its 50-day average volume of 753,070. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}